PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Cancer Research|2024Cited by 56
Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402Atsushi Kudo, Masakazu Yamamoto, Masahiro Shinoda et al.|Journal of Cancer Research and Clinical Oncology|2020Cited by 16
Metformin Inhibits the Development and Metastasis of Colorectal CancerKiyoaki Sugiura, Yuko Kitagawa|Research Square|2021Cited by 1
Supplementary Fig.S4 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0
Supplementary Fig.S8 from PRMT1 Sustains <i>De Novo</i> Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast CancerTakehiro Yamamoto, Makoto Suematsu, Tetsu Hayashida et al.|Unknown|2024Cited by 0